Bio-Techne to Present at Upcoming Investor Conferences

Bio-Techne (NASDAQ: TECH) will present at four investor conferences in November 2025.

Rhea-AI Summary

Bio-Techne (NASDAQ: TECH) will present at four investor conferences in November 2025. Scheduled presentations:

• UBS Global Healthcare — November 10, 2025 at 10:15 AM ET
• Stifel Healthcare — November 11, 2025 at 9:20 AM ET
• Stephens Investment — November 18, 2025 at 8:00 AM CT
• Jefferies Global Healthcare — November 20, 2025 at 12:30 PM GMT

A live webcast will be available via the company's Investor Relations Calendar at https://investors.bio-techne.com/ir-calendar.

Argus Nov 6 session

-2.94% close to close Open Argus

Details

News Market Reaction – TECH

On Nov 6, the day this news came out, TECH closed 2.94% below the previous close.

Data tracked by StockTitan Argus for the Nov 6 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MINNEAPOLIS, Nov. 6, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences:

UBS Global Healthcare Conference 2025
November 10, 2025
10:15 AM EST

Stifel 2025 Healthcare Conference
November 11, 2025
9:20 AM EST

Stephens Investment Conference
November 18, 2025
8:00 AM CST

Jefferies Global Healthcare Conference
November 20, 2025
12:30 PM GMT

A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated over $1.2 billion in net sales in fiscal 2025 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at: LinkedIn, X or YouTube.

Contact:	David Clair, Vice President, Investor Relations & Corporate Development
	david.clair@bio-techne.com

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-upcoming-investor-conferences-302605528.html

SOURCE Bio-Techne Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Bio-Techne (TECH) present at the UBS Global Healthcare Conference?

Bio-Techne will present on November 10, 2025 at 10:15 AM ET.

How can I watch Bio-Techne's (TECH) presentations live in November 2025?

A live webcast is available on the company's Investor Relations Calendar at https://investors.bio-techne.com/ir-calendar.

What time is Bio-Techne (TECH) presenting at the Stifel 2025 Healthcare Conference?

The Stifel presentation is scheduled for November 11, 2025 at 9:20 AM ET.

When is Bio-Techne (TECH) presenting at the Stephens Investment Conference?

Bio-Techne is scheduled to present on November 18, 2025 at 8:00 AM CT.

What is the date and time for Bio-Techne (TECH) at the Jefferies Global Healthcare Conference?

The Jefferies presentation is on November 20, 2025 at 12:30 PM GMT.

Will Bio-Techne (TECH) post slides or a replay after the November 2025 investor presentations?

Presentations will be webcast live via the Investor Relations Calendar; replay and materials are typically posted there after each event.